Latest Articles

Publication Date
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Nigeria

Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Nigeria

Published: July 2, 2025, 12:52 p.m.
Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain - MarketScreener

Organon Provides Update on Phase 2 ELENA Proof-Of-Concept Study Evaluating OG-6219 in Patients with Endometriosis-Related Pain MarketScreener

Published: July 2, 2025, 12:51 p.m.
Organon's OG-6219 Failure: A Crossroads for Women's Health Innovation and Financial Strategy - AInvest

Organon's OG-6219 Failure: A Crossroads for Women's Health Innovation and Financial Strategy AInvest

Published: July 2, 2025, 12:47 p.m.
Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint - MarketScreener

Organon Ends Development of OG-6219 After Endometriosis Trial Fails to Meet Primary Endpoint MarketScreener

Published: July 2, 2025, 12:10 p.m.
Organon halts development of endometriosis pain drug after trial failure By Investing.com - Investing.com Canada

Organon halts development of endometriosis pain drug after trial failure By Investing.com Investing.com Canada

Published: July 2, 2025, 12:08 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MarketScreener

Organon to halt development of endometriosis pain drug after mid-stage trial failure MarketScreener

Published: July 2, 2025, 11:52 a.m.
Organon abandons endometriosis pain drug development after trial failure - MarketScreener

Organon abandons endometriosis pain drug development after trial failure MarketScreener

Published: July 2, 2025, 11:52 a.m.
Organon halts development of endometriosis pain drug after trial failure - Investing.com

Organon halts development of endometriosis pain drug after trial failure Investing.com

Published: July 2, 2025, 11:42 a.m.
Doctor shares 6 causes of painful periods after pregnancy and how to reduce pain | Health - Hindustan Times - Hindustan Times

Doctor shares 6 causes of painful periods after pregnancy and how to reduce pain | Health - Hindustan Times Hindustan Times

Published: July 2, 2025, 8:39 a.m.
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country - Express Pharma

AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Express Pharma

Published: July 2, 2025, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!